FR2379534A1 - 1-thienyl- et furyl-2,3,4,5-tetrahydro-1h-3-benzazepine substituees - Google Patents

1-thienyl- et furyl-2,3,4,5-tetrahydro-1h-3-benzazepine substituees

Info

Publication number
FR2379534A1
FR2379534A1 FR7802275A FR7802275A FR2379534A1 FR 2379534 A1 FR2379534 A1 FR 2379534A1 FR 7802275 A FR7802275 A FR 7802275A FR 7802275 A FR7802275 A FR 7802275A FR 2379534 A1 FR2379534 A1 FR 2379534A1
Authority
FR
France
Prior art keywords
benzazepine
furyl
tetrahydro
thienyl
substitutes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7802275A
Other languages
English (en)
Other versions
FR2379534B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline LLC
Original Assignee
SmithKline Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Corp filed Critical SmithKline Corp
Publication of FR2379534A1 publication Critical patent/FR2379534A1/fr
Application granted granted Critical
Publication of FR2379534B1 publication Critical patent/FR2379534B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms

Abstract

L'invention a pour objet des composés de formule :
FR7802275A 1977-02-02 1978-01-27 1-thienyl- et furyl-2,3,4,5-tetrahydro-1h-3-benzazepine substituees Granted FR2379534A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/764,672 US4111957A (en) 1977-02-02 1977-02-02 Substituted 1-thienyl and furyl-2,3,4,5-tetrahydro-1H-3-benzazepine compounds

Publications (2)

Publication Number Publication Date
FR2379534A1 true FR2379534A1 (fr) 1978-09-01
FR2379534B1 FR2379534B1 (fr) 1981-11-27

Family

ID=25071413

Family Applications (2)

Application Number Title Priority Date Filing Date
FR7802275A Granted FR2379534A1 (fr) 1977-02-02 1978-01-27 1-thienyl- et furyl-2,3,4,5-tetrahydro-1h-3-benzazepine substituees
FR7820342A Granted FR2383929A1 (fr) 1977-02-02 1978-07-07 1-hydroxy 2, 3, 4, 5-tetrahydro-1h-3-benzazepines substituees

Family Applications After (1)

Application Number Title Priority Date Filing Date
FR7820342A Granted FR2383929A1 (fr) 1977-02-02 1978-07-07 1-hydroxy 2, 3, 4, 5-tetrahydro-1h-3-benzazepines substituees

Country Status (6)

Country Link
US (1) US4111957A (fr)
JP (2) JPS5395989A (fr)
BE (1) BE868868A (fr)
DE (1) DE2804285A1 (fr)
FR (2) FR2379534A1 (fr)
GB (1) GB1599705A (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0002327A1 (fr) * 1977-11-17 1979-06-13 Smithkline Beckman Corporation 6-Alcoyl inférieur-7,8- dihydroxy-1-phényl-2,3,4,5-tétrahydro-1H-3- benzazépines, leurs méthodes de préparation et intermédiaires
FR2441615A1 (fr) * 1978-11-20 1980-06-13 Pennwalt Corp Procede de production de 1,2,4,5-tetrahydro-7-alcoxy-(et 7,8-dialkoxy)-3h,3-benzazepines et de leurs derives substitues en position 3 a partir des phenethylamines correspondantes et derives obtenus
EP0200455A2 (fr) * 1985-04-22 1986-11-05 Novo Nordisk A/S 2,3,4,5-tetrahydro-1H-3-benzazépines substituées en position 5

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4352754A (en) * 1976-11-17 1982-10-05 Smithkline Corporation 3-Thienylmethyl-6-halo-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines
ZA792785B (en) * 1978-07-07 1980-08-27 Smithkline Corp Mercapto substituted-2,3,4,5-tetrahydro-1h-3-benzazepines
US4255445A (en) * 1980-03-07 1981-03-10 Smithkline Corporation 8-Hydroxy-6,7-(2-methyl-2,3-dihydrofuro)-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines
US4769368A (en) * 1986-02-10 1988-09-06 Smithkline Beckman Corporation 2,3,4,8,9,9A-Hexahydro-4-aryl-1H-indeno(1,7-CD)azepines
DK67489D0 (da) * 1989-02-14 1989-02-14 Novo Industri As Nye benzazepinderivater
JPH03153111A (ja) * 1989-11-09 1991-07-01 Murata Mfg Co Ltd 弾性表面波発振器
GB9903671D0 (en) * 1999-02-17 1999-04-14 Cenes Ltd Dopamine D-1 receptor agonist compounds
US6953787B2 (en) 2002-04-12 2005-10-11 Arena Pharmaceuticals, Inc. 5HT2C receptor modulators
EA016558B1 (ru) * 2003-06-17 2012-05-30 Арена Фармасьютикалз, Инк. Производные бензазепина, используемые для лечения заболеваний, ассоциированных с 5-ht-рецептором
HUE028976T2 (en) * 2003-06-17 2017-02-28 Arena Pharm Inc 8-Chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride
US20080009478A1 (en) * 2003-10-22 2008-01-10 Arena Pharmaceuticals, Inc. Benzazepine Derivatives and Methods of Prophylaxis or Treatment of 5Ht2c Receptor Associated Diseases
WO2005042490A1 (fr) * 2003-10-22 2005-05-12 Arena Pharmaceuticals, Inc. Derives de benzazepine et methodes de prophylaxie ou de traitement de maladies associees au recepteur 5-ht2c
JP5270167B2 (ja) 2004-12-21 2013-08-21 アリーナ ファーマシューティカルズ， インコーポレイテッド （ｒ）−８−クロロ−１−メチル−２，３，４，５−テトラヒドロ−１ｈ−３−ベンザゼピン塩酸塩の結晶形
CN102631349A (zh) 2004-12-23 2012-08-15 艾尼纳制药公司 5HT2c受体调节剂组合物和使用方法
JP5199997B2 (ja) 2006-04-03 2013-05-15 アリーナ ファーマシューティカルズ， インコーポレイテッド ８−クロロ−１−メチル−２，３，４，５−テトラヒドロ−１ｈ−３−ベンズアゼピンおよびこれに関連する中間体を調製するためのプロセス
CN101547892B (zh) * 2006-12-05 2014-08-20 艾尼纳制药公司 制备(r)-8-氯-1-甲基-2,3,4,5-四氢-1h-3-苯并氮杂卓的方法和其中间体
JP4933325B2 (ja) * 2007-03-29 2012-05-16 原田工業株式会社 接続端子構造
JP5491421B2 (ja) * 2008-03-04 2014-05-14 アリーナ ファーマシューティカルズ， インコーポレイテッド ５−ｈｔ２ｃアゴニストである（ｒ）−８−クロロ−１−メチル−２，３，４，５−テトラヒドロ−１ｈ−３−ベンゾアゼピンに関連する中間体の調製のためのプロセス
WO2010148207A2 (fr) 2009-06-18 2010-12-23 Arena Pharmaceuticals, Inc. Procédés pour la préparation d'agonistes du récepteur 5-ht2c
WO2011153206A1 (fr) 2010-06-02 2011-12-08 Arena Pharmaceuticals, Inc. Procédés pour la préparation d'agonistes du récepteur 5-ht2c
SG10201506870PA (en) 2010-09-01 2015-10-29 Arena Pharm Inc Salts of lorcaserin with optically active acids
SG188362A1 (en) 2010-09-01 2013-04-30 Arena Pharm Inc Modified-release dosage forms of 5-ht2c agonists useful for weight management
US8999970B2 (en) 2010-09-01 2015-04-07 Arena Pharmaceuticals, Inc. Administration of an anti-obesity compound to individuals with renal impairment
EP2611433A2 (fr) 2010-09-01 2013-07-10 Arena Pharmaceuticals, Inc. Sels non hygroscopiques d'agonistes de 5-ht2c
KR20150070249A (ko) 2012-10-09 2015-06-24 아레나 파마슈티칼스, 인크. 체중 관리 방법

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3609138A (en) * 1967-12-22 1971-09-28 Ciba Geigy Corp 1-aryl-3-benzazepines

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3393192A (en) * 1965-04-26 1968-07-16 Schering Corp Novel benzazepines
US3663532A (en) * 1970-03-04 1972-05-16 American Home Prod Benzodiazocines

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3609138A (en) * 1967-12-22 1971-09-28 Ciba Geigy Corp 1-aryl-3-benzazepines

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0002327A1 (fr) * 1977-11-17 1979-06-13 Smithkline Beckman Corporation 6-Alcoyl inférieur-7,8- dihydroxy-1-phényl-2,3,4,5-tétrahydro-1H-3- benzazépines, leurs méthodes de préparation et intermédiaires
FR2422641A1 (fr) * 1977-11-17 1979-11-09 Smithkline Corp 7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepines
EP0026505A1 (fr) * 1977-11-17 1981-04-08 Smithkline Beckman Corporation 1-Phényl-2,3,4,5-tétrahydro 1-H-3-benzazépines 7,8-substituées
FR2441615A1 (fr) * 1978-11-20 1980-06-13 Pennwalt Corp Procede de production de 1,2,4,5-tetrahydro-7-alcoxy-(et 7,8-dialkoxy)-3h,3-benzazepines et de leurs derives substitues en position 3 a partir des phenethylamines correspondantes et derives obtenus
EP0200455A2 (fr) * 1985-04-22 1986-11-05 Novo Nordisk A/S 2,3,4,5-tetrahydro-1H-3-benzazépines substituées en position 5
EP0200455A3 (en) * 1985-04-22 1987-07-29 Novo Industri A/S Nitrogen containing compounds

Also Published As

Publication number Publication date
JPS62161764A (ja) 1987-07-17
DE2804285A1 (de) 1978-08-03
FR2383929B1 (fr) 1981-07-31
FR2379534B1 (fr) 1981-11-27
JPS6341912B2 (fr) 1988-08-19
JPS5395989A (en) 1978-08-22
DE2804285C2 (fr) 1988-01-07
BE868868A (fr) 1979-01-10
FR2383929A1 (fr) 1978-10-13
GB1599705A (en) 1981-10-07
US4111957A (en) 1978-09-05

Similar Documents

Publication Publication Date Title
FR2379534A1 (fr) 1-thienyl- et furyl-2,3,4,5-tetrahydro-1h-3-benzazepine substituees
FR2392671A1 (fr) Application pharmacologique des acides d2-3-1,4-morpholine-2-carboxyliques substitues
FR2381763A1 (fr) Dibenzo(b-e) (diazepines-1,4) et leur utilisation comme antischizophreniques
FR2375218A1 (fr) 2-imidazoline-5-ones a substitution chirale
FR2389605A1 (fr)
FR2444681A1 (fr) Nouvelles 1,4-dihydropyridines, leur preparation et leur application comme medicaments
FR2372165A1 (fr)
FR2378016A1 (fr) 1-alkylthiophenyl-2,3,4,5-tetrahydro-1h-3-benzazepine substituees et leur application en therapeutique
FR2361376A1 (fr) Nouveaux tetrazoles
FR2366276A1 (fr) Aza-13 prostaglandines
FR2389608A1 (fr)
FR2360583A1 (fr) B-azolylcetones utiles comme fongicides
FR2383944A1 (fr) Derives de bis-benzimidazolyle substitues, leur procede de preparation et leur application en therapeutique
FR2369276A1 (fr) Nouve
FR2367761A1 (fr) Derives piperidylideniques de benzo-xanthenes,
FR2354317A1 (fr) Benzyl-cyanoacetals, leur preparation et leur utilisation pour des syntheses chimiques
FR2384759A1 (fr) 1-phenyl-2,3,4,5 tetrahydro-1h benzazepine-7,8-diones
FR2446284A1 (fr) Tetrahydro-benzo(c)quinoleine-9(8h)ones
FR2389615A1 (fr)
FR2422641A1 (fr) 7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepines
FR2382431A1 (fr) Nouvelles 2-hydroxy-propylamines, leur preparation et leur utilisation comme agents tensio-actifs
FR2369279A1 (fr) 8-(1h-tetrazol-5-yl)-11h-pyrido(2,1-b)quinazolin-11-ones et leur application pharmacologique
FR2401932A1 (fr) Intermediaires de synthese pour la preparation d'imidazoles substitues
FR2355840A1 (fr) Nouveaux derives de l'oxadiazole-5-thiol
FR2378519A1 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse